Her primary scientific interests are in Virology, Influenza A virus, Viral replication, Virus and Orthomyxoviridae. Her study in Virology is interdisciplinary in nature, drawing from both Sphingosine and Hamster. Her studies deal with areas such as RNA, Molecular biology, Nucleoprotein, Cell biology and Cell nucleus as well as Influenza A virus.
Her Viral replication research focuses on Neuraminidase and how it connects with Reverse genetics. Her research in Virus intersects with topics in Mesocricetus and Pathogenesis. Drug development, Antiviral drug, Interactome and Host factor is closely connected to Viral life cycle in her research, which is encompassed under the umbrella topic of Orthomyxoviridae.
The scientist’s investigation covers issues in Virology, Virus, Viral replication, Influenza A virus and Influenza A virus subtype H5N1. Her study on Orthomyxoviridae, Ebola virus and Neuraminidase is often connected to Pandemic as part of broader study in Virology. Her Virus study incorporates themes from Pathogenesis, Host, Immune system and Antigen.
Her Viral replication study combines topics in areas such as Vesicular stomatitis virus, Gene and Antiviral drug. Her research integrates issues of RNA, Nucleoprotein, Mutation and Hemagglutinin in her study of Influenza A virus. Her study looks at the relationship between Helper virus and topics such as Reverse genetics, which overlap with Vero cell and Polymerase.
Tokiko Watanabe mostly deals with Virology, Virus, Immune system, Adjuvant and Pathogenicity. Her study in the fields of Neutralizing antibody, Influenza A virus and Ebola virus under the domain of Virology overlaps with other disciplines such as Pandemic. Tokiko Watanabe interconnects Cell culture, Virus genetics, Receptor, Human Virus and Mutation in the investigation of issues within Influenza A virus.
Her study in Influenza A virus subtype H5N1 and Viral replication is carried out as part of her Virus studies. Her Viral replication research is multidisciplinary, incorporating perspectives in Antiviral drug, Computational biology and Host factors. Her Adjuvant research includes elements of Influenza vaccine, Vaccination and Outbreak.
Tokiko Watanabe spends much of her time researching Virus, Virology, Influenza A virus, Viral replication and Neutralizing antibody. Her work on Antiviral drug as part of general Virus research is frequently linked to Subnetwork, bridging the gap between disciplines. Her Virology research incorporates themes from Mutation, Cell culture and Antigen.
Her Influenza A virus research integrates issues from Influenza A virus subtype H5N1, Highly pathogenic, Inoculation and Receptor. Her Viral replication study integrates concerns from other disciplines, such as Immune system, Computational biology, Host factors and Protein–protein interaction. The concepts of her Neutralizing antibody study are interwoven with issues in Mesocricetus, Hamster and Pathogenesis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
Masaki Imai;Tokiko Watanabe;Masato Hatta;Subash C. Das.
Nature (2012)
Generation of influenza A viruses entirely from cloned cDNAs
Gabriele Neumann;Tokiko Watanabe;Hiroshi Ito;Shinji Watanabe.
Proceedings of the National Academy of Sciences of the United States of America (1999)
In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses
Yasushi Itoh;Kyoko Shinya;Maki Kiso;Tokiko Watanabe.
Nature (2009)
Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Masaki Imai;Kiyoko Iwatsuki-Horimoto;Masato Hatta;Samantha Loeber.
Proceedings of the National Academy of Sciences of the United States of America (2020)
Drosophila RNAi screen identifies host genes important for influenza virus replication
Linhui Hao;Akira Sakurai;Tokiko Watanabe;Ericka Sorensen.
Nature (2008)
Characterization of H7N9 influenza A viruses isolated from humans
Tokiko Watanabe;Maki Kiso;Satoshi Fukuyama;Noriko Nakajima.
Nature (2013)
Selective incorporation of influenza virus RNA segments into virions
Yutaka Fujii;Hideo Goto;Tokiko Watanabe;Tetsuya Yoshida.
Proceedings of the National Academy of Sciences of the United States of America (2003)
Cellular Networks Involved in the Influenza Virus Life Cycle
Tokiko Watanabe;Shinji Watanabe;Yoshihiro Kawaoka.
Cell Host & Microbe (2010)
Biological and structural characterization of a host-adapting amino acid in influenza virus.
Shinya Yamada;Masato Hatta;Bart L. Staker;Shinji Watanabe.
PLOS Pathogens (2010)
Involvement of host cellular multivesicular body functions in hepatitis B virus budding
Tokiko Watanabe;Ericka M. Sorensen;Akira Naito;Meghan Schott.
Proceedings of the National Academy of Sciences of the United States of America (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Tokyo
University of Wisconsin–Madison
National Institutes of Health
University of Wisconsin–Madison
Kyoto University
Kobe University
Hokkaido University
Okinawa Institute of Science and Technology
National Institutes of Health
Hokkaido University
University of Cambridge
Texas Instruments (United States)
University of Palermo
Lehigh University
University of Electronic Science and Technology of China
Sanford Burnham Prebys Medical Discovery Institute
Netherlands Environmental Assessment Agency
University of Göttingen
University of Udine
Université Paris Cité
Montana State University
University of North Carolina at Chapel Hill
University of Antwerp
Stanford University
University of Glasgow
Klein Buendel